This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Identifying patient details (age and sex) have been obtained through direct communication with the author.
Herishanu Y, et al. Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. American Journal of Hematology 95: 604-611, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1002/ajh.25766